Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), MRCP (UK), MRCP (Edinburg), MRCP (Glassgow)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), MRCP (UK), MRCP (Edinburg), MRCP (Glassgow)
Internal Medicine Specialist
MBBS, FCPS Gastroenterology, MRCP (UK), MRCPE (UK), MACG (USA)
Internal Medicine Specialist
MBBS, FCPS Gastroenterology, MRCP (UK), MRCPE (UK), MACG (USA)
Internal Medicine Specialist
MBBS, FCPS Medicine, MRCP - UK
Internal Medicine Specialist
MBBS, FCPS
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S.
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S, Dip. In (Diabetes) (USA), Dip. In (Gastroenterology) (USA)
Internal Medicine Specialist
M.B.B.S, F.C.P.S, Dip. In (Diabetes) (USA), Dip. In (Gastroenterology) (USA)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures